These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27273343)

  • 1. Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.
    Groll AH; Desai A; Han D; Howieson C; Kato K; Akhtar S; Kowalski D; Lademacher C; Lewis W; Pearlman H; Mandarino D; Yamazaki T; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):76-85. PubMed ID: 27273343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects.
    Desai A; Yamazaki T; Dietz AJ; Kowalski D; Lademacher C; Pearlman H; Akhtar S; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):86-92. PubMed ID: 27278712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic Evaluation of CYP3A4-Mediated Drug-Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults.
    Townsend R; Dietz A; Hale C; Akhtar S; Kowalski D; Lademacher C; Lasseter K; Pearlman H; Rammelsberg D; Schmitt-Hoffmann A; Yamazaki T; Desai A
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):44-53. PubMed ID: 27273461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Interaction Between Isavuconazole and a Fixed-Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects.
    Yamazaki T; Desai A; Han D; Kato K; Kowalski D; Akhtar S; Lademacher C; Kovanda L; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):93-101. PubMed ID: 27273248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects.
    Yamazaki T; Desai A; Goldwater R; Han D; Howieson C; Akhtar S; Kowalski D; Lademacher C; Pearlman H; Rammelsberg D; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):54-65. PubMed ID: 27273149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects.
    Yamazaki T; Desai A; Goldwater R; Han D; Lasseter KC; Howieson C; Akhtar S; Kowalski D; Lademacher C; Rammelsberg D; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):66-75. PubMed ID: 27273004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Drug-Drug Interactions Between Letermovir and the Immunosuppressants Cyclosporine, Tacrolimus, Sirolimus, and Mycophenolate Mofetil.
    McCrea JB; Macha S; Adedoyin A; Marshall W; Menzel K; Cho CR; Liu F; Zhao T; Levine V; Kraft WK; Yoon E; Panebianco D; Stoch SA; Iwamoto M
    J Clin Pharmacol; 2019 Oct; 59(10):1331-1339. PubMed ID: 30990905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic Interactions Between Elbasvir/Grazoprevir and Immunosuppressant Drugs in Healthy Volunteers.
    Feng HP; Caro L; Fandozzi CM; Guo Z; Talaty J; Wolford D; Panebianco D; Iwamoto M; Butterton JR; Yeh WW
    J Clin Pharmacol; 2018 May; 58(5):666-673. PubMed ID: 29329497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of mycophenolate mofetil in renal transplant recipients receiving standard-dose or low-dose cyclosporine, low-dose tacrolimus or low-dose sirolimus: the Symphony pharmacokinetic substudy.
    Grinyó JM; Ekberg H; Mamelok RD; Oppenheimer F; Sánchez-Plumed J; Gentil MA; Hernandez D; Kuypers DR; Brunet M
    Nephrol Dial Transplant; 2009 Jul; 24(7):2269-76. PubMed ID: 19357111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Drug Interaction Between Isavuconazole and Tacrolimus: Is Empiric Dose Adjustment Necessary?
    Kufel WD; Armistead PM; Daniels LM; Ptachcinski JR; Alexander MD; Shaw JR
    J Pharm Pract; 2020 Apr; 33(2):226-230. PubMed ID: 30049245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study.
    Kieu V; Jhangiani K; Dadwal S; Nakamura R; Pon D
    Transpl Infect Dis; 2019 Feb; 21(1):e13007. PubMed ID: 30295407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isavuconazole absorption following oral administration in healthy subjects is comparable to intravenous dosing, and is not affected by food, or drugs that alter stomach pH.
    Schmitt-Hoffmann A; Desai A; Kowalski D; Pearlman H; Yamazaki T; Townsend R
    Int J Clin Pharmacol Ther; 2016 Aug; 54(8):572-80. PubMed ID: 27345284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
    Sansone-Parsons A; Krishna G; Martinho M; Kantesaria B; Gelone S; Mant TG
    Pharmacotherapy; 2007 Jun; 27(6):825-34. PubMed ID: 17542765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics.
    Townsend RW; Akhtar S; Alcorn H; Berg JK; Kowalski DL; Mujais S; Desai AV
    Eur J Clin Pharmacol; 2017 Jun; 73(6):669-678. PubMed ID: 28271239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment.
    Büchler M; Lebranchu Y; Bénéton M; Le Meur Y; Heng AE; Westeel PF; le Guellec C; Libert F; Hary L; Marquet P; Paintaud G
    Clin Pharmacol Ther; 2005 Jul; 78(1):34-42. PubMed ID: 16003290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of mycophenolate mofetil and sirolimus in children.
    Filler G; Bendrick-Peart J; Christians U
    Ther Drug Monit; 2008 Apr; 30(2):138-42. PubMed ID: 18367972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients.
    Kozuch JM; Burt C; Afshar K; Aslam S; Yung G; Mariski M; Golts E; Feist A
    Transpl Infect Dis; 2024 Feb; 26(1):e14209. PubMed ID: 38059638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A and tacrolimus combined with enteric-coated mycophenolate sodium influence the plasma mycophenolic acid concentration - a randomised controlled trial in Chinese live related donor kidney transplant recipients.
    Huang HF; Yao X; Chen Y; Xie WQ; Shen-Tu JZ; Chen JH
    Int J Clin Pract Suppl; 2014 Apr; (181):4-9. PubMed ID: 24673713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus.
    Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Fernandes FB; Casarini DE; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2009 Feb; 23(1):137-45. PubMed ID: 19267777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.